Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease. Buchheit KM, Lewis E, Gakpo D, Hacker J, et al. J Allergy Clin Immunol 2021;148:574-584.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Buchheit KM, Lewis E, Gakpo D, Hacker J, et al. Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2021;148:574-584.
PMID: 34144111